Evaluation of Aqueous Humor DEL-1 and IL-17 Levels in Diabetic Cataract Patients
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-80
SponsorUşak University
About this trial
By comparing DEL-1 and IL-17 levels in the aqueous humor of diabetic cataract patients with the aqueous humor of non-diabetic patients, we aim to understand the biochemical effects of diabetes-related inflammatory processes in the eye.
Eligibility criteria
Qualifiers
Cataract diagnosed and surgery planned
Patients without any other ocular pathology other than cataract.
Type 2 DM for at least 5 years in the diabetic group
Disqualifiers
Patients with previous intraocular surgery
Those with inflammatory eye diseases (e.g. uveitis)
Those with autoimmune diseases or systemic inflammatory diseases
Those receiving local or systemic steroid therapy
Trial design
Treatments tested in this trial
- Del 1
- IL 17
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov